Board professional Eva Sjökvist Saers new chairman of Dicot
Press release: Uppsala, February 9, 2021. At an Extraordinary General Meeting on February 9, Dr Eva Sjökvist Saers was elected new Chairman of the Board of Dicot, which is developing a potency drug for erectile dysfunction and premature ejaculation. Eva acts as a board member in several life science companies, she is chairman of Vinnova's strategic innovation program Swelife and has an industrial background from AstraZeneca and as CEO of APL.On February 9, a unanimous meeting elected Dr Eva Sjökvist Saers as the new Chairman of the Board of the pharmaceutical company Dicot. She thereby